A new way of picking market-beating stocks
Over the long term, these stocks are above-average performers
Over the long term, these stocks are above-average performers
UBS analysts on Monday called Bank of America the “most interesting money center,” as major banks approach second-quarter earnings season later this week.
Forecast contracts allow investors to place a bet that something will or won’t happen.
Biden labeled Trump’s plan to institute a universal 10% tariff on imported goods to the U.S. a “national sales tax,” that would cost Americans $2,500 per year.
Providing long-term care is one of the biggest challenges facing an aging society
The airline sector traded mostly higher Monday, after data showed there were more travelers at the end of the July 4 weekend than on any day last year or in 2019.
The recent weakness of bitcoin could signal an imminent correction of the S&P 500 in the summer, as the two assets often trade in tandem.
“It’s the old ‘buy the rumor, sell the news’ adage,” says a market source.
The U.S. stock market’s rally is facing a test that begins this week with company earnings.
AMC’s CEO touted visitors to the movie-theater chain this weekend — as well as purchases made for merchandise.
Jim Stoeffel and Brendan Hartman of Royce Investment Partners have a “picks-and-shovels” approach to AI-based computing infrastructure.
Nvidia’s stock is staging a sharp rally on an upbeat day for the chip sector.
The German company said the penalty “for alleged anti-competitive” violations could could ultimately exceed €400 million ($433 million),
Lucid’s stock rallied Monday, after the electric-vehicle maker reported a big jump in deliveries in the second quarter.
Wolfe Research cuts JPMorgan to peer perform and highlights Bank of America as an outperforming stock.
Koss shares were down 15.4% in premarket trades Monday, putting it on pace to snap a two-day winning streak.
HilleVax Inc.’s stock cratered 89% early Monday, after the biotech said it would discontinue development of a vaccine against norovirus for infants after a trial missed its main goals.
Guggenheim says the monetization of generative AI “is not happening en masse and is not likely to materialize this year.”
Ubisoft’s strategic pivot towards subscriptions and the release of two new games could boost the French company’s share price, Jefferies analysts said
Not all chip stocks enjoyed the exuberant first-half performance seen by Nvidia — and a Melius Research analyst thinks some notable laggards could be primed for solid rebounds.